E
Elizabeth J. Thomson
Researcher at National Institutes of Health
Publications - 38
Citations - 33253
Elizabeth J. Thomson is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Genetic testing & Hemochromatosis. The author has an hindex of 23, co-authored 38 publications receiving 28655 citations. Previous affiliations of Elizabeth J. Thomson include University of California, Los Angeles & Baylor College of Medicine.
Papers
More filters
Journal ArticleDOI
Cancer Genetic Susceptibility Testing: Ethical and Policy Implications for Future Research and Clinical Practice
TL;DR: It is suggested that more data are needed on the long-term physical and psychosocial effects of testing and that further examination is needed of the ethical issues raised by testing.
Journal ArticleDOI
Screening for cystic fibrosis carrier state.
Michael T. Mennuti,Elizabeth J. Thomson,Elizabeth J. Thomson,Elizabeth J. Thomson,Nancy Press,Nancy Press,Nancy Press +6 more
TL;DR: This commentary reviews the discussions that occurred and the conclusions that were reached at a workshop convened to discuss the implementation of cystic fibrosis carrier screening recommendations and concludes that those populations to whom carrier screening should be offered might include individuals and couples in high-risk groups who seek preconception counseling, infertility care, or prenatal care.
Journal ArticleDOI
Patient acceptability of genotypic testing for hemochromatosis in primary care
Roger T. Anderson,Nancy Press,Diane C. Tucker,Beverly M. Snively,Lari Wenzel,Shellie D. Ellis,Mark A. Hall,Ann P. Walker,Elizabeth J. Thomson,Ometha Lewis-Jack,Ronald T. Acton +10 more
TL;DR: Patient education regarding the nature of test, importance of disease detection, and privacy protection appear to be essential for achieving high rates of screening participation.
Journal ArticleDOI
Impact of hemochromatosis screening in patients with indeterminate results: The hemochromatosis and iron overload screening study
Roger T. Anderson,Lari Wenzel,Ann P. Walker,Andrea Ruggiero,Ronald T. Acton,Mark A. Hall,Diane C. Tucker,Elizabeth J. Thomson,Barbara Harrison,Edmund G Howe,Joan Holup,Catherine Leiendecker-Foster,Tara E Power,Paul C. Adams +13 more
TL;DR: Notification of indeterminate results from screening may be associated with mild negative effects on well-being, and might be a potential participant risk in screening programs for disorders with uncertain genotype-phenotype.